During the past decade, Incheon St. Mary's Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 3 clinical trials were completed, i.e. on average, 13% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Incheon St. Mary's Hospital" #1 sponsor was "Incheon St.Mary's Hospital" with 10 trials, followed by "The Catholic University of Korea" with 3 trials sponsored, "Catholic Kwandong University" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Gachon University Gil Oriental Medical Hospital" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Incheon St. Mary's Hospital" #1 collaborator was "Incheon St.Mary's Hospital" with 3 trials as a collaborator, "CardioVascular Research Foundation, Korea" with 2 trials as a collaborator, "Catholic Kwandong University" with 2 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator and "Inje University" with 2 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Incheon St. Mary's Hospital" are "Coronary Artery Disease" (3 trials), "Postoperative Nausea and Vomiting" (3 trials), "Atopic Dermatitis" (2 trials), "Atrial Fibrillation" (2 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Incheon St. Mary's Hospital" in a lesser frequency.

Most popular intervention types in "Incheon St. Mary's Hospital" are "Drug" (22 trials), "Procedure" (4 trials), "Device" (3 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Lebrikizumab" (2 trials), "Abilify maintena" (1 trials), "Acetyl-L-carnitine hydrochloride 500mg" (1 trials) and "Acupuncture and Usual care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Incheon St. Mary's Hospital" are 33 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Incheon St. Mary's Hospital". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Incheon St. Mary's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Incheon St. Mary's Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 13 trials that are defined as “Not Applicable".